Khan A A, Nawaz M S, Khan S A, Cerniglia C E
Division of Microbiology, Food and Drug Administration, National Center for Toxicological Research, Jefferson, AR 72079, USA.
FEMS Microbiol Lett. 2000 Jan 15;182(2):355-60. doi: 10.1111/j.1574-6968.2000.tb08921.x.
Salmonella typhimurium definitive type 104 (DT104) is a virulent pathogen for humans and animals with many strains having multiple drug resistance characteristics. The organism typically carries resistance to ampicillin, chloramphenicol, florfenicol, streptomycin, sulfonamides, and tetracycline (ACSSuT-resistant). A multiplex PCR method was developed to simultaneously amplify four genes, florfenicol (flo(st)), virulence (spvC), invasion (invA), and integron (int) from S. typhimurium DT104 (ACSSuT-type). Twenty-two ACSSuT-resistant DT104 isolates in our collection gave 100% positive reactions to this PCR assay by amplifying 584-, 392-, 321- and 265-bp PCR products, using primers specific to the respective target genes. One Salmonella strain DT23, ACSSuT-resistant, phage type 711 failed to amplify the 584-bp fragment, indicating that this method is specific for DT104-type ACSSuT-resistant S. typhimurium strains. One clinical and one bovine ASSuT-resistant strains that were sensitive to chloramphenicol and florfenicol did not yield a 584-bp fragment, indicating the absence of the flo(st) gene. This method will be useful for rapid identification of ACSSuT-type DT104 strains from clinical, food and environmental samples.
鼠伤寒沙门氏菌定型 104(DT104)是一种对人类和动物具有致病性的病原体,许多菌株具有多重耐药特性。该菌通常对氨苄青霉素、氯霉素、氟苯尼考、链霉素、磺胺类药物和四环素耐药(耐ACSSuT)。开发了一种多重PCR方法,用于同时从鼠伤寒沙门氏菌DT104(ACSSuT型)中扩增四个基因,即氟苯尼考(flo(st))、毒力(spvC)、侵袭(invA)和整合子(int)。我们收集的22株耐ACSSuT的DT104分离株,通过使用各自靶基因特异性引物扩增出584、392、321和265bp的PCR产物,对该PCR检测呈100%阳性反应。一株耐ACSSuT的噬菌体711型沙门氏菌DT23未能扩增出584bp片段,表明该方法对DT104型耐ACSSuT的鼠伤寒沙门氏菌菌株具有特异性。一株对氯霉素和氟苯尼考敏感的临床菌株和一株牛源耐ASSuT菌株未产生584bp片段,表明不存在flo(st)基因。该方法将有助于从临床、食品和环境样本中快速鉴定ACSSuT型DT104菌株。